Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « J. L. Montastruc »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J. L. Houeto < J. L. Montastruc < J. L. Sarmiento  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000646 (1998) C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; S. Bullman [Royaume-Uni] ; D. R. Citerone [Royaume-Uni] ; A. C. Taylor [Royaume-Uni] ; J. L. Montastruc [France] ; O. Rascol [France]Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients
000647 (1998) U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni]Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
000661 (1997) U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni] ; A. Dubini [Italie] ; N. Orlando [Italie] ; R. Grimaldi [Italie]Cabergoline in the treatment of early Parkinson's disease : Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Chemotherapy
3Human
3Parkinson disease
3Treatment
2Antiparkinson agent
2Cabergoline
2Double blind study
2Early
2Ergot derivatives
1Aged
1Agonist
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (pharmacokinetics)
1Antiparkinson Agents (therapeutic use)
1Area Under Curve
1Comparative study
1Controlled therapeutic trial
1D2 Dopamine receptor
1Dopamine agonist
1Fasting
1Female
1Food drug interaction
1Food-Drug Interactions
1Half-Life
1Humans
1Indoles (adverse effects)
1Indoles (pharmacokinetics)
1Indoles (therapeutic use)
1Levodopa
1Male
1Middle Aged
1Multicenter study
1Multiple dose
1Oral administration
1Parkinson Disease (drug therapy)
1Parkinson Disease (metabolism)
1Pharmacokinetics
1Prevention
1Randomization
1Ropinirole
1Toxicity

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "J. L. Montastruc" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "J. L. Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    J. L. Montastruc
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024